Diabetes mellitus is not a disease. It is a syndrome of altered metabolism resulting in, among other things, hyperglycaemia. While there are a number of different diseases which cause this syndrome 99.8% of diabetic patients in Western countries have either type I (insulin dependent, juvenile onset) or type 2 (non-insulin-depend ent, maturity onset) diabetes. These are quite distinct path ological entities, albeit that many of the complications of the two diseases are common. 
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NOR MAL HUMAN PANCREAS
Pancreatic islets occupy approximately 2-5% of the total pancreatic mass in adults. Four distinct endocrine cell types are found within the islets: glucagon-secreting A cells, insulin-secreting B cells, somatostatin-secreting D cells and pancreatic-polypeptide-secreting PP cells. In the body and tail of pancreas approximately 82% of cells are B cells, 13% are A cells, 4% are D cells and I % are PP cells. I In the posterior part of the head of pancreas PP cells are much more common (79%), and this part of the gland, which has a different embryological origin from the rest of the pancreas, is called the PP rich lobe.
THE PANCREAS IN TYPE 1 DIABETES
In type I diabetes there is selective destruction of insulin secreting B cells within the pancreas. Although patients with type I diabetes may present clinically with a rela tively acute illness there is evidence that the destruction of B cells proceeds very slowly and may well have been pres ent for years before diagnosis.2 Only when approximately 80% of the B cells have been destroyed will the patient decompensate metabolically.
If the pancreas of a patient who has had the disease for many years is examined, virtually no B cells will be found and the islets will consist only of A, D and PP cells. By contrast, at clinical presentation of the disease, there are essentially three morphological types of islet. Firstly, approximately 70% of the islets are devoid of B cells (,insulin deficient islets') ( Fig. 1) . Secondly, there are Eye (1993) 7, [197] [198] [199] [200] [201] islets which are histologically normal and which have a normal complement of B cells. Thirdly, there are' islets which show signs of chronic inflammation and which exhibit a variable reduction in the number of B cells (Fig. 2) .' This inflammatory process, associated with the selective destruction of B cells, is termed insulitis. 4 In a study of a single case, in which frozen material was available, the majority of lymphocytes in the insulitis infiltrate were T cells, with a predominance of those belonging to the CD8 phenotype (cytotoxic/suppressor cells). While helper T lymphocytes and natural killer cells were also present in small numbers macrophages were inconspicuous." These findings, taken in conjunction with the fact that insulitis preferentially affects islets which contain residual B cells, makes it seem very likely that insulitis represents the immunologically mediated, selec tive destruction of B cells. If loss of B cells is truly a very slow process one would expect to find insulitis before and after clinical presentation. This is indeed the case. It has been seen in patients who were thought to be prediabetic6.7 and it was also found affecting insulin-containing islets in the pancreas of a child who had had clinical diabetes for six years. 3 The fact that such a slow destruction of B cells results in their total disappearance testifies to their very limited regenerative capacity.
There is now good evidence that type 1 diabetes repre sents an autoimmune disease in which the B cell is tar geted for destruction.s Several immunopathological abnormalities in the islets have been described which may help to point to the pathological process leading to autoimmunity.
There is a marked genetic component to the development of diabetes which is linked to the class II major histocom patibility complex (MHC) genes (HLA-DR, -DP and -DQ in man).9 The proteins coded by these genes are expressed on the surface of certain cells and are intimately involved in antigen presentation. Normally T helper lymphocytes, the cells which initiate the immune response, only recog nise the antigen to which they are directed if the antigen is presented to them by cells which express class II MHC molecules. Many cells in the body, including pancreatic B cells, do not normally express class II MHC molecules. Thus, even if there were potentially autoreactive T lym phocytes present which could recognise antigens on these cells, they would not react because the antigens would not be 'presented' to them in the context of class II MHC. This may be one mechanism of tolerance. Bottazzo et al. IO (Fig. 3) .5.11-13
Hyperexpression of Class I MHC Whilst helper T lymphocytes can only recognise the anti gen to which they are directed in the context of class II MHC molecules, cytotoxic T lymphocytes, which are the cells most likely to be responsible for destroying islet B cells, recognise antigen only in the presence of class I MHC (HLA-A, -B and -C in man). Islet B cells, in com mon with most nucleated cells in the body, normally express these molecules. However, hyperexpression of class I MHC molecules may make them more susceptible to the action of cytotoxic T lymphocytes.
In pancreases from patients with recent onset type 1 diabetes the great majority of islets containing residual B cells hyperexpressed class 1 MHC whilst islets which were deficient in B cells were not thus affected. Within affected islets A, D and PP cells, as well as B cells, hyper expressed class I MHC. As with aberrant expression of class II MHC by B cells this abnormality appeared unique to type 1 diabetes.12
Intelferon-alpha in B Cells
As has been described above, A and D cells hyper expressed class I MHC when they were adjacent to B cells in insulin-containing islets. However, when they were physically divorced from B cells, in insulin-deficient islets, they ceased to hyperexpress this product. This, in conjunction with the fact that many islets which hyper expressed class I MHC did not appear to be inflamed, sug gested that the B cells may be secreting some factor which could cause adjacent endocrine cells to hyperexpress class I MHC. One substance capable of doing this ill vitro is interferon-alpha. In an immunohistochemical study of 37 diabetic pancreases immunoreactive interferon-alpha, confined to B cells, was found in 93% of islets which hyperexpressed class I MHC but only in 0.4% of those showing no hyperexpression (Fig. 4) . Among 80 pan creases from non-diabetic patients or patients with type 2 diabetes significant numbers of B cells containing inter feron-alpha were present only in 4 cases of acute infantile Coxsackie viral pancreatitis.14 This raised the possibility that B cells in diabetes could be infected by a virus. Ser ological studies of newly diagnosed patients with type I diabetes have also suggested that viral infection could be implicated in the pathogenesis of the disease."17
Insights infO the Possible Pathogenesis of Type 1
Diabetes
The concordance rate in monozygotic twins for auto immune diabetes is no more than 50%, indicating that environmental factors as well as genetic susceptibility play a role in the pathogenesis of the disease. Chief among the environmental suspects are viruses, particularly Cox sackie, mumps and rubella viruses.IS-17 The finding that B cells in both diabetes and Coxsackie viral pancreatitis express interferon-alpha raises the possibility that B cells are chronically infected by a virus in diabetes. This infec tion is not likely to be cytopathic, given the long time (Fig. 5) . It is present in up to 90% of cases and can affect up to 80% of the islets. Recently the peptide of the amyloid in pancreatic islets was identi fied?o.21 Islet amyloid polypeptide (lAPP) (also called 'amylin') is a 37 amino acid peptide with structural hom ology to calcitonin gene-related peptide. This peptide is a normal secretory product of pancreatic B cells.
The role of amyloid in the pathogenesis of type 2 diabetes remains to be clarified. The anatomical disrup tion to the islet caused by the amyloid is unlikely to be the cause of the diabetes for two reasons: (1) not all patients with type 2 diabetes have islet amyloid, and (2) most patients with systemic amyloidosis in whom there are sig- 
